Gerald J. Duke

459 total citations
10 papers, 298 citations indexed

About

Gerald J. Duke is a scholar working on Molecular Biology, Organic Chemistry and Surgery. According to data from OpenAlex, Gerald J. Duke has authored 10 papers receiving a total of 298 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 2 papers in Organic Chemistry and 2 papers in Surgery. Recurrent topics in Gerald J. Duke's work include Lipoproteins and Cardiovascular Health (2 papers), Melanoma and MAPK Pathways (2 papers) and Synthesis of Tetrazole Derivatives (1 paper). Gerald J. Duke is often cited by papers focused on Lipoproteins and Cardiovascular Health (2 papers), Melanoma and MAPK Pathways (2 papers) and Synthesis of Tetrazole Derivatives (1 paper). Gerald J. Duke collaborates with scholars based in United States, Germany and Sweden. Gerald J. Duke's co-authors include Bowman Miao, Rex A. Parker, Kevin Kish, John S. Sack, Dianlin Xie, Fabienne Denhez, Herbert E. Klei, Tiziano Bandiera, Siew Peng Ho and Marina Fasolini and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Journal of Hepatology.

In The Last Decade

Gerald J. Duke

10 papers receiving 291 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerald J. Duke United States	7	160	126	49	36	33	10	298
James W. Jetter United States	11	142 0.9×	59 0.5×	14 0.3×	19 0.5×	25 0.8×	12	319
Francesc Salvà Spain	13	132 0.8×	54 0.4×	13 0.3×	43 1.2×	15 0.5×	34	467
John-Paul Jimenez United States	6	335 2.1×	24 0.2×	47 1.0×	60 1.7×	18 0.5×	8	381
Dean Messing United States	10	139 0.9×	17 0.1×	36 0.7×	35 1.0×	18 0.5×	14	281
Jane Alder United Kingdom	12	252 1.6×	25 0.2×	13 0.3×	20 0.6×	18 0.5×	16	438
Charles Kasiewski United States	13	100 0.6×	62 0.5×	7 0.1×	17 0.5×	15 0.5×	17	334
Yugandhar Beesetty United States	5	177 1.1×	53 0.4×	8 0.2×	55 1.5×	14 0.4×	7	310
Vojo Vukovic United States	7	277 1.7×	10 0.1×	31 0.6×	54 1.5×	10 0.3×	13	440
Asiya Khan India	9	125 0.8×	41 0.3×	8 0.2×	48 1.3×	7 0.2×	18	288
Susanna Stinson United States	3	175 1.1×	16 0.1×	20 0.4×	15 0.4×	10 0.3×	4	265

Countries citing papers authored by Gerald J. Duke

Since Specialization

Citations

This map shows the geographic impact of Gerald J. Duke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald J. Duke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald J. Duke more than expected).

Fields of papers citing papers by Gerald J. Duke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald J. Duke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald J. Duke. The network helps show where Gerald J. Duke may publish in the future.

Co-authorship network of co-authors of Gerald J. Duke

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald J. Duke. A scholar is included among the top collaborators of Gerald J. Duke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald J. Duke. Gerald J. Duke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Halpern, Otto, Javed Khan, Gregory Locke, et al.. (2021). Small molecule and macrocyclic pyrazole derived inhibitors of myeloperoxidase (MPO). Bioorganic & Medicinal Chemistry Letters. 42. 128010–128010. 8 indexed citations

Duke, Gerald J., Allan S. Wagman, Douglas Buckley, William McCulloch, & George Kemble. (2017). Establishing the foundation for a novel, first-in-class, fatty acid synthase inhibitor, TVB-2640, for the treatment of NASH. Journal of Hepatology. 66(1). S99–S100. 4 indexed citations

Mitchell, Tracy, Ginger Chao, Doree Sitkoff, et al.. (2014). Pharmacologic Profile of the Adnectin BMS-962476, a Small Protein Biologic Alternative to PCSK9 Antibodies for Low-Density Lipoprotein Lowering. Journal of Pharmacology and Experimental Therapeutics. 350(2). 412–424. 103 indexed citations

Kim, Soong‐Hoon, Keith L. Constantine, Gerald J. Duke, et al.. (2013). Design, synthesis, functional and structural characterization of an inhibitor of N-acetylneuraminate-9-phosphate phosphatase: Observation of extensive dynamics in an enzyme/inhibitor complex. Bioorganic & Medicinal Chemistry Letters. 23(14). 4107–4111. 4 indexed citations

Sack, John S., Sandrine Thieffine, Tiziano Bandiera, et al.. (2011). Structural basis for CARM1 inhibition by indole and pyrazole inhibitors. Biochemical Journal. 436(2). 331–339. 75 indexed citations

Benjannet, Suzanne, Yascara Grisel Luna Saavedra, Josée Hamelin, et al.. (2010). Effects of the Prosegment and pH on the Activity of PCSK9. Journal of Biological Chemistry. 285(52). 40965–40978. 54 indexed citations

Wrobleski, Stephen T., Shuqun Lin, John Hynes, et al.. (2008). Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2739–2744. 25 indexed citations

Sack, John S., Kevin Kish, Matthew Pokross, et al.. (2008). Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase. Acta Crystallographica Section D Biological Crystallography. 64(7). 705–710. 10 indexed citations

Gandhi, Rajesh, et al.. (2007). Use of Microcalorimetry and Its Correlation with Size Exclusion Chromatography for Rapid Screening of the Physical Stability of Large Pharmaceutical Proteins in Solution. Pharmaceutical Development and Technology. 12(3). 265–273. 14 indexed citations

10.

O'Keefe, Donald O. & Gerald J. Duke. (2000). Fast quantitation of recombinant plasminogen activator inhibitor type 1 in bacterial lysates by micropellicular reversed-phase liquid chromatography. Journal of Chromatography A. 891(1). 85–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact